Want to see IN:STAR full AI Analyst Report?
Strides Pharma Science Ltd (STAR) Income Statement
Strides Pharma Science Ltd Income Statement
Last quarter (Q4 2026), Strides Pharma Science Ltd's total revenue was $13.23B, an increase of 11.18% from the same quarter last year. In Q4, Strides Pharma Science Ltd's net income was $1.27B. See Strides Pharma Science Ltd’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 48.59B | $ 44.75B | $ 38.28B | $ 36.68B | $ 30.59B | |
| $ 17.69B | $ 11.83B | $ 8.51B | $ 8.05B | $ 4.11B | |
| $ 10.46B | $ 6.65B | $ 5.49B | $ 6.82B | $ 6.63B | |
| Depreciation and Amortization | $ 2.02B | $ 1.92B | $ 2.21B | $ 2.43B | $ 2.33B |
| $ 10.50B | $ 9.28B | $ 3.86B | $ 2.18B | $ -2.43B | |
| $ 7.23B | $ 5.18B | $ 3.02B | $ 1.24B | $ -2.52B | |
| $ -542.06M | $ -313.81M | $ -4.17B | $ -4.10B | $ -4.01B | |
| $ 6.69B | $ 4.87B | $ -1.15B | $ -2.86B | $ -6.53B | |
| $ 5.56B | $ 4.05B | $ -1.20B | $ -2.21B | $ -4.60B | |
| Per Share Metrics | |||||
| Basic EPS | $ 60.34 | $ 44.05 | $ -13.21 | $ -24.56 | $ -51.28 |
| Diluted EPS | $ 60.34 | $ 44.05 | $ -13.21 | $ -24.56 | $ -51.28 |
| Weighted Average Shares Outstanding | 92.18M | 92.01M | 91.00M | 90.08M | 89.75M |
| Weighted Average Shares Outstanding (Diluted) | 92.18M | 92.02M | 91.13M | 90.09M | 89.75M |
Currency in INR
